Study Identifies RAPGEF3 as a Target to Overcome Lung Cancer Drug Resistance
Author Information
Author(s): Wang Hua, Tang Shijie, Wu Qibiao, He Yayi, Zhu Weikang, Xie Xinyun, Qin Zhen, Wang Xue, Zhou Shiyu, Yao Shun, Xu Xiaoling, Guo Chenchen, Tong Xinyuan, Han Shuo, Chou Yueh-Hung, Wang Yong, Wong Kwok-Kin, Yang Cai-Guang, Chen Luonan, Hu Liang, Ji Hongbin
Primary Institution: Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences
Hypothesis
The study investigates the link between adeno-to-squamous transition (AST) and resistance to EGFR tyrosine kinase inhibitors (TKIs) in lung cancer.
Conclusion
The findings suggest that targeting RAPGEF3 can effectively overcome TKI resistance in lung cancer associated with squamous transition.
Supporting Evidence
- Squamous transition occurs alongside TKI resistance in lung cancer models.
- FOXA1 plays a crucial role in maintaining adenomatous lineage and TKI sensitivity.
- Pharmacological inhibition of RAPGEF3 can effectively overcome TKI resistance.
- Integrative analyses reveal a transcriptional network involved in AST and TKI resistance.
- Clinical samples show increased RAPGEF3 expression in relapsed patients.
Takeaway
This study shows that some lung cancer cells can change from one type to another, making them harder to treat, but a specific target can help make treatments work again.
Methodology
The study used RNA-seq, ATAC-seq, and functional studies to analyze the mechanisms of AST and TKI resistance.
Potential Biases
Potential biases may arise from the selection of samples and the specific models used in the study.
Limitations
The study's findings are based on a limited number of clinical samples and may not be generalizable to all lung cancer cases.
Participant Demographics
The study primarily involved patients with EGFR-mutant lung adenocarcinoma, particularly in Eastern Asian populations.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website